|Bid||17.25 x 0|
|Ask||17.50 x 0|
|Day's range||16.81 - 17.40|
|52-week range||1.25 - 23.00|
|Beta (5Y monthly)||0.48|
|PE ratio (TTM)||N/A|
|Earnings date||17 Mar 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||10.00|
It's difficult to pick your own shares successfully – research consistently shows that more than half of retail investors in the UK and US who pick their own s...
Just because a business does not make any money, does not mean that the stock will go down. Indeed, e-Therapeutics...
It's a good time to be a shareholder in E-Therapeutics (LON:ETX): as the share approaches its 52-week high, holders may be wondering whether to sell and take t8230;
While it may not be enough for some shareholders, we think it is good to see the e-Therapeutics plc (LON:ETX) share...